FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Zeta Gets Navigation System Improvements Cleared

FDA clears a Zeta Surgical 510(k) for its Zeta Navigation System for use with expanded instruments and enhanced hospital connectivity.

latest-news-card-1
Medical Devices

Advisors Asked for ProSense Benefits, Risks

FDA raises questions to be considered by members of its General and Plastic Surgery Advisory Committee about IceCare Medicals ProSense cryoblation sys...

Medical Devices

FDA OKs LumiThera Dry AMD Treatment

FDA grants de novo authorization to LumiTheras Valeda light delivery treatment for dry age-related macular degeneration.

latest-news-card-1
Human Drugs

Caris Companion Diagnostic for Cancer Approved

FDA approves Caris Life Sciences MI Cancer Seek and its use as a companion diagnostic to identify cancer patients for treatment with several targeted ...

latest-news-card-1
Medical Devices

ACLA Views on PCCP Draft Guidance

The American Clinical Laboratory Association submits comments to an FDA draft guidance on medical device predetermined change control plans.

latest-news-card-1
FDA General

RFK Jr. Says Some FDA Departments Have to Go

In an interview the day after the election, president-elect Donald Trumps top health advisor Robert F. Kennedy Jr. says there are some FDA departments...

latest-news-card-1
Medical Devices

Breakthrough Designation for SeaStar Dialysis Device

FDA grants a fourth breakthrough device designation for SeaStar Medicals Selective Cytopheretic Device.

latest-news-card-1
Human Drugs

Objectionable Conditions at Hospital IRB

FDA warns the Kittanning, PA-based Armstrong County Memorial Hospital IRB about objectionable conditions identified in a Bioresearch Monitoring Progra...

latest-news-card-1

FDA Cant Regulate AI on its Own: Califf

FDA commissioner Robert Califf says collaboration with external stakeholders is needed to adequately monitor and regulate artificial intelligence.

latest-news-card-1
Human Drugs

Acadia Unloads Priority Voucher for $150 Million

Acadia Pharmaceuticals sells its Rare Pediatric Disease Priority Review Voucher for $150 million.